5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 4.24▼ | 4.23▲ | 4.23▲ | 4.28▲ | 4.08▲ |
MA10 | 4.25▼ | 4.22▲ | 4.22▲ | 4.25▲ | 4.03▲ |
MA20 | 4.22▲ | 4.22▲ | 4.23▲ | 4.07▲ | 4.33▼ |
MA50 | 4.24▼ | 4.28▼ | 4.27▼ | 4.02▲ | 5.20▼ |
MA100 | 4.27▼ | 4.19▲ | 4.09▲ | 4.31▼ | 47.82▼ |
MA200 | 4.16▲ | 4.10▲ | 4.02▲ | 4.73▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.006▲ | 0.004▲ | 0.000▲ | 0.023▲ | 0.388▲ |
RSI | 50.341▲ | 50.360▲ | 49.987▼ | 56.221▲ | 43.112▼ |
STOCH | 54.524 | 72.222 | 52.981 | 56.533 | 54.062 |
WILL %R | -50.000 | -38.095 | -36.667 | -31.348 | -46.746 |
CCI | 48.185 | 75.233 | 53.151 | 37.439 | 22.964 |
Tuesday, April 29, 2025 12:00 AM
Primary Endpoints Demonstrate CTx-1301 Can be Taken With or Without Food. CTx-1301 is Designed as a True, Entire Active-Day Treatment for ADHD. KANSAS CITY, Kan., April 29, 2025 ( ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 4.3214 | 4.3214 | 4.145 | 4.30 | 28,189 |
30/04/25 | 4.16 | 4.325 | 4.00 | 4.21 | 123,667 |
29/04/25 | 4.19 | 4.35 | 4.16 | 4.26 | 254,537 |
28/04/25 | 4.30 | 4.4552 | 4.22 | 4.35 | 111,036 |
25/04/25 | 4.34 | 4.51 | 4.16 | 4.30 | 115,485 |
24/04/25 | 4.40 | 4.40 | 4.25 | 4.34 | 78,900 |
23/04/25 | 4.291 | 4.44 | 4.2185 | 4.25 | 104,059 |
22/04/25 | 4.20 | 4.20 | 4.11 | 4.16 | 139,696 |
21/04/25 | 4.03 | 4.28 | 4.03 | 4.07 | 93,500 |
17/04/25 | 4.20 | 4.2699 | 4.0402 | 4.24 | 60,953 |
|
|
||||
|
|
||||
|
|